2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing CancersSolid TumorsActive, not recruitingPhase 12026-08-26NCT03448042
Minima Stent System Post- Approval Study (PAS)Arterial Occlusive Diseases, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Stenosis, Pulmonary Artery, aorta coarctation, cardiovascular disorder, congenital heart disease, heart disorder, vascular disorderRecruitingNot stated2025-10-23NCT06828770